{"title":"非小细胞肺癌患者DAPK基因和p16基因启动子超甲基化的研究","authors":"Shi-ying Zheng, D. Jiang, J. Ge","doi":"10.1109/BMEI.2009.5305423","DOIUrl":null,"url":null,"abstract":"bjective�÷ To evaluate the clinical significan ce of the aberrant methylation of DAPK gene and p16 gene in serum from 65 NSCLC patients from the first affiliated hospital of suzhou university� Mothods �÷ A methylation-specific PCR (MSP)was performed for the detection of promoter hypermethylation of DAPK gene and p16 gene in blood DNA from 65 cases of NSCLC� and to analyze the relation of the aberrant methylation of DAPK gene and p16 gene and the clinicopathological data� Results�÷ 30.8�i (20�A65)of the sera from 65 cases of NSCLC showed hypermethylation for DAPK promoter and 43.1�i (28�A 65)the same for p16 promoter�» whereas no methylated DAPK gene promoter and p16 gene promoter were found in sera from the patients with lung benign diseases and normal controls� Methylated DAPK gene promoter and p16 gene promoter in sera were not closely correlated with the pathological classification �» stage �»metastas is and differentiation in NSCLC� Conclusion�÷ Detection of the aberrant methylation of DAPK gene and p16 gene in blood DNA from NSCLC patients might offer an effective meaa-lS for the earlier auxiliar y diagnosis of the malignancy�","PeriodicalId":6389,"journal":{"name":"2009 2nd International Conference on Biomedical Engineering and Informatics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2009-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The Promoter Hypermethylation of DAPK Gene and p16 Gene in Non-Small Cell Lung Cancer Patients\",\"authors\":\"Shi-ying Zheng, D. Jiang, J. Ge\",\"doi\":\"10.1109/BMEI.2009.5305423\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"bjective�÷ To evaluate the clinical significan ce of the aberrant methylation of DAPK gene and p16 gene in serum from 65 NSCLC patients from the first affiliated hospital of suzhou university� Mothods �÷ A methylation-specific PCR (MSP)was performed for the detection of promoter hypermethylation of DAPK gene and p16 gene in blood DNA from 65 cases of NSCLC� and to analyze the relation of the aberrant methylation of DAPK gene and p16 gene and the clinicopathological data� Results�÷ 30.8�i (20�A65)of the sera from 65 cases of NSCLC showed hypermethylation for DAPK promoter and 43.1�i (28�A 65)the same for p16 promoter�» whereas no methylated DAPK gene promoter and p16 gene promoter were found in sera from the patients with lung benign diseases and normal controls� Methylated DAPK gene promoter and p16 gene promoter in sera were not closely correlated with the pathological classification �» stage �»metastas is and differentiation in NSCLC� Conclusion�÷ Detection of the aberrant methylation of DAPK gene and p16 gene in blood DNA from NSCLC patients might offer an effective meaa-lS for the earlier auxiliar y diagnosis of the malignancy�\",\"PeriodicalId\":6389,\"journal\":{\"name\":\"2009 2nd International Conference on Biomedical Engineering and Informatics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2009 2nd International Conference on Biomedical Engineering and Informatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/BMEI.2009.5305423\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2009 2nd International Conference on Biomedical Engineering and Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/BMEI.2009.5305423","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
bjective�÷评估的临床significan ce DAPK基因的异常甲基化和p16基因从65名非小细胞肺癌患者血清从苏州大学第一附属医院�方法�÷进行聚合酶链反应(MSP) methylation-specific DAPK基因启动子甲基化的检测和p16基因在血液DNA从65例NSCLC�和分析DAPK基因的异常甲基化的关系和p16基因和临床病理的数据结果��÷30.8�我(20�A65)的65例非小细胞肺癌血清显示为DAPK启动子甲基化和43.1�我对于p16(28�65)相同的启动子�»而没有和p16基因甲基化DAPK基因启动子中发现血清肺良性疾病患者和正常对照组�和p16基因甲基化DAPK基因启动子血清并不密切相关的病理分类��»»阶段结论metastas和分化在NSCLC��÷异常的检测非小细胞肺癌患者血液DNA中DAPK基因和p16基因的甲基化可能为恶性肿瘤的早期辅助诊断提供一种有效的手段
The Promoter Hypermethylation of DAPK Gene and p16 Gene in Non-Small Cell Lung Cancer Patients
bjective�÷ To evaluate the clinical significan ce of the aberrant methylation of DAPK gene and p16 gene in serum from 65 NSCLC patients from the first affiliated hospital of suzhou university� Mothods �÷ A methylation-specific PCR (MSP)was performed for the detection of promoter hypermethylation of DAPK gene and p16 gene in blood DNA from 65 cases of NSCLC� and to analyze the relation of the aberrant methylation of DAPK gene and p16 gene and the clinicopathological data� Results�÷ 30.8�i (20�A65)of the sera from 65 cases of NSCLC showed hypermethylation for DAPK promoter and 43.1�i (28�A 65)the same for p16 promoter�» whereas no methylated DAPK gene promoter and p16 gene promoter were found in sera from the patients with lung benign diseases and normal controls� Methylated DAPK gene promoter and p16 gene promoter in sera were not closely correlated with the pathological classification �» stage �»metastas is and differentiation in NSCLC� Conclusion�÷ Detection of the aberrant methylation of DAPK gene and p16 gene in blood DNA from NSCLC patients might offer an effective meaa-lS for the earlier auxiliar y diagnosis of the malignancy�
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
